Outpatient Drug and Alcohol Rehab Clinic Helps Woman With Substance Addiction
Outpatient Drug and Alcohol Rehab Clinic helps Woman with Substance Addiction – After losing faith in everything including her church, the outpatient drug and alcohol rehab clinic at Brighton Center for Recovery helps rehabilitate a woman with poly substance addiction to alcohol and crack. The best drug and alcohol addiction help is what Brighton is all about. Brighton Center for Recovery is the second oldest alcohol treatment program in the United States and the first to be licensed in Michigan . A national leader in drug and alcohol treatment and counseling services that began in the early 1950’s. Additionally, we treat addictions to: meth, marijuana, pot, crack, heroin, cocaine, speed, oxycontin, coke, prescription pain pills, ecstasy, plus. Our clinics’ rehabilitation treatment programs include: dual diagnosis treatment, teen and young adult, CEO,lawyer and judges recovery, 30-60-90 day recovery programs, and men’s and women’s halfway houses.
LIBERAL & PROUD
Filed under: outpatient drug treatment programs
Another mental health diagnosis that should not be subject to HIPAA is addiction. Addicts lie, and that is the nature of the disease. It doesn't matter if the drug of choice is alcohol, prescription medication or street drugs. Inpatient treatment …
Read more on WND.com
Texas' largest addiction–treatment nonprofits merge
Filed under: outpatient drug treatment programs
The Council on Alcohol and Drugs Houston, the largest nonprofit provider of outpatient drug and alcohol addiction treatment services in Texas, has merged with Austin Recovery. The Austin entity is the largest nonprofit provider of residential drug and …
Read more on Houston Business Journal (blog)
Drug Pipelines Begin to Fill For Big Pharma
Filed under: outpatient drug treatment programs
"It has the potential of doubling the revenues of the company and bringing it to about a billion dollars of revenues in the future," Bienaime said of the treatment. He expects to file for approval with the Food and Drug Administration by the end of the …
Read more on CNBC.com